(Q46152291)

20 December 2017

title

Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in Ewing sarcoma (English)

1 reference

20 December 2017

author name string

Shawnagay Nestheide

1

1 reference

20 December 2017

Julia A Bridge

2

1 reference

20 December 2017

Michael Barnes

3

1 reference

20 December 2017

Robert Frayer

4

1 reference

20 December 2017

Janos Sumegi

5

1 reference

20 December 2017

publication date

18 March 2013

1 reference

20 December 2017

published in

Pediatric Blood & Cancer

1 reference

20 December 2017

volume

60

1 reference

20 December 2017

issue

9

1 reference

20 December 2017

page(s)

1437-1446

1 reference

20 December 2017

Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets

cites work

1 reference

Mesenchymal stem cell features of Ewing tumors

21 January 2018

1 reference

Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies

21 January 2018

1 reference

CGH analysis of secondary genetic changes in Ewing tumors: correlation with metastatic disease in a series of 43 cases

21 January 2018

1 reference

The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts

21 January 2018

1 reference

Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse

21 January 2018

1 reference

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

21 January 2018

1 reference

Epigenetics and microRNAs

21 January 2018

1 reference

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

21 January 2018

1 reference

Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells

21 January 2018

1 reference

Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma

21 January 2018

1 reference

MethPrimer: designing primers for methylation PCRs

21 January 2018

1 reference

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.

21 January 2018

1 reference

Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.

21 January 2018

1 reference

Putative biological functions of the DAZ family

21 January 2018

1 reference

Identification of a novel human cancer/testis gene MAEL that is regulated by DNA methylation

21 January 2018

1 reference

Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis

21 January 2018

1 reference

ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study.

21 January 2018

1 reference

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

21 January 2018

1 reference

Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation

21 January 2018

1 reference

21 January 2018

1 reference

Chapter 5: Nuclear CLU (nCLU) and the fate of the cell.

21 January 2018

1 reference

Effects of clusterin over-expression on metastatic progression and therapy in breast cancer

21 January 2018

1 reference

Clusterin is epigenetically regulated in prostate cancer

21 January 2018

1 reference

Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation.

21 January 2018

1 reference

Genomic characterisation of a Fgf-regulated gradient-based neocortical protomap

21 January 2018

1 reference

Mest/Peg1 inhibits Wnt signalling through regulation of LRP6 glycosylation

21 January 2018

1 reference

Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest

21 January 2018

1 reference

Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancer

21 January 2018

1 reference

Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma

21 January 2018

1 reference

A microarray-based DNA methylation study of glioblastoma multiforme

21 January 2018

1 reference

The fetal and neonatal brain protein neuronatin protects PC12 cells against certain types of toxic insult

21 January 2018

1 reference

Ectopic expression of Neuronatin potentiates adipogenesis through enhanced phosphorylation of cAMP-response element-binding protein in 3T3-L1 cells

21 January 2018

1 reference

Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia

21 January 2018

1 reference

Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.

21 January 2018

1 reference

Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.

21 January 2018

1 reference

DNA methylation and gene expression profiling of ewing sarcoma primary tumors reveal genes that are potential targets of epigenetic inactivation

21 January 2018

1 reference

A Ewing's sarcoma cell line showing some, but not all, of the traits of a cholinergic neuron

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.24526

1 reference

20 December 2017

1 reference

20 December 2017